Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: Photo/Multimedia, Personnel

Rick Melnick Joins DunhamTrimmer


DunhamTrimmer, the market leader in business intelligence for the biocontrols and biostimulants industries, announced today it has named Rick Melnick the company's new Vice President of Global Business. As an established professional in the biocontrols space, Melnick brings 25 years of experience in agriculture, marketing, communications, and business management to the organization.

The move marks another key hire for DunhamTrimmer, the company that has emerged as the pre-eminent resource for clients seeking data and business intelligence relating to biocontrols and biostimulant markets, technologies, and distribution strategies around the world.

"Rick brings a truly unique combination of knowledge, experience, and capabilities to our organization," said Mark Trimmer, DunhamTrimmer's Managing Partner. "His passion, vision, and proven leadership within the biocontrols arena are well-known and highly regarded. He makes a formidable addition to our team and positions us for continued growth and success in the biocontrols/biostimulants markets."

Melnick is outgoing Chairman of the Board of Directors of the Biological Products Industry Alliance (BPIA), a US-based trade association representing the biocontrols and biostimulants industries. He is also a former president of BioProtection Global, the global association of biocontrols trade organizations. In his 25-year career, Melnick has served in Director positions with both Valent BioSciences and Meister Media Worldwide.

"I am honored and excited to be joining an organization as successful and well respected as DunhamTrimmer," said Melnick. "I know from experience it is a company known for exceeding expectations, and I intend to carry on in that tradition."

DunhamTrimmer is currently at the Biostimulants World Congress in Barcelona promoting its new Biostimulants Global Market Report, due out in January. For more information on the report, email or visit dunhamtrimmer.com.

About DunhamTrimmer

DunhamTrimmer is the premier business management, strategic marketing, market research and intelligence firm with a singular focus on the Global Biological Markets for agriculture (biocontrol/biopesticide, biostimulant and biofertilizer sectors). Since 2011, DunhamTrimmer has been serving their clients with detailed custom single client studies as well as a variety of reports on the companies and products in these sectors. The company counts among its diverse range of clients, global crop protection and global fertilizer companies, biopesticide, biostimulant & biofertilizer manufacturers, investment firms, and food producers/processors/marketing companies.


These press releases may also interest you

at 03:00
Sadly, senior citizens are among the first to suffer from exposure to COVID-19. Living in close quarters is one of the highest contributing factors to exposure but the team from San Luis Obispo's Elder Placement Professionals has prepared some...

4 jui 2020
SummaryProducts: Cetrotide 0.25mg Issue: One lot of Cetrotide 0.25mg is being recalled because some vials may have missing stoppers, which could make the product unsterile. What to do: Check the lot number on your product or contact your pharmacist...

4 jui 2020
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "There have been 105,091 cases of COVID-19 in Canada, including 8,663 deaths. 65% of people have now recovered....

4 jui 2020
The latest data of the evolution of COVID-19 in Québec reveal 102 new cases over the past 24 hours, bringing the total number of people infected to 55,784. During the same period, 3 new deaths were recorded, to which are added 3 deaths that occurred...

4 jui 2020
On Friday, the British government announced that, as of July 10th, those travelling from the Commonwealth of Dominica to England need not self-isolate for 14 days. Dominica is one of the 59 countries and 14 British Overseas Territories forming a...

4 jui 2020
Gilead Sciences, Inc. today announced data from an ongoing Phase 1 study, which showed that a sustained-delivery subcutaneous formulation of the company's investigational, novel inhibitor of HIV-1 capsid function, lenacapavir (GS-6207), sustained...



News published on 19 november 2019 at 13:50 and distributed by: